Kate Sutherland

15PUBLICATIONS
63CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHumoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 05, 2026
SMARCA4 Loss Promotes Late-Stage Tumor Progression in Nonneuroendocrine Small Cell Lung Cancer.

Nicole A Kirk, Jin Ng, Kate-Lin Ly

|Oct 01, 2025
SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer.

Nicole A Kirk, Jin Ng, Kate-Lin Ly

|Nov 20, 2024
Breathing new insights into the role of mutant p53 in lung cancer.

Tianwei Chen, Lauren M Ashwood, Olga Kondrashova

|Jan 05, 2024
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.

Jin Ng, Ling Cai, Luc Girard

|Feb 04, 2023
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells.

Zilu Wang, Huimin Hu, Luuk Heitink

Pageof 3